QUCY:NASDAQMainz Biomed N.V. Analysis
Data as of 2026-09-07 - not real-time
$1.59
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Quantum Cyber N.V. is priced at $1.59 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 47.2%. Relative strength is 58.9 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $1.23 and resistance at $1.65.
The average analyst target implies 466.0% above today's level.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 90.8%, a beta of 3.55 and a maximum drawdown of 81.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 2/10 long-term conviction.
The average analyst target implies 466.0% above today's level.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 90.8%, a beta of 3.55 and a maximum drawdown of 81.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 2/10 long-term conviction.
Top Market Events
WEST PALM BEACH, Florida, July 06, 2026 GLOBE NEWSWIRE -- Quantum Cyber N.As Federal Funding Floods The Drone Market, Quantum Cyber N.ADVFN1monQuantum Cyber shares rise after subsidiary secures $2.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 1.19
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 1.19
- Analyst targets imply +466.0% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply +466.0% versus the current price
- Negative return on equity of -212.5%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
ROE-212.53%
ROA-64.88%
Debt/Equity0.83
P/B Ratio2.0
Op. Cash Flow$-14252458
Free Cash Flow$-7630069
Industry P/E30.6
Technical Analysis
TrendBullish
RSI58.9
Support$1.23
Resistance$1.65
MA 20$1.43
MA 50$1.35
MA 200$1.19
MACDBullish
VolumeIncreasing
Fear & Greed Index94.11
Valuation
Target Price$9.00
Upside/Downside466.04%
GradeUndervalued
TypeBlend
Risk Assessment
Beta3.55
Volatility90.83%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.